Merial sells St. Louis pharmaceutical blending facility to Huvepharma
04.05.2007 | General News
Duluth, Ga., May 4, 2007 - Merial, Limited, and Huvepharma, Inc. announced that Merial has sold its St. Louis blending facility and rights to certain anticoccidial products to Huvepharma. The sale was effective April 27, 2007.
Huvepharma and Merial have also reached an agreement for transfer of marketing rights for a number of products manufactured at the site, which are mainly anticoccidials for use in poultry:
- AMPROL® (amprolium) 25% Premix
- AMPROL® 20% Soluble Powder
- AMPROL® 9.6% Solution
- AMPROL® (amprolium/ethopabate) Plus
- COYDEN® (clopidol) 25% Premix
AMPROL®, COYDEN and CORID are registered trademarks of Merial.
As part of the agreement, Huvepharma will also supply Merial with certain cattle anticoccidial products, which are also manufactured at the site. These products bear the CORID® (amprolium) trademark.
RSS Feed